Jump to content

Cancer immunotherapy: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

1 October 2024

15 September 2024

6 September 2024

16 July 2024

21 June 2024

16 June 2024

7 June 2024

4 June 2024

14 May 2024

12 May 2024

10 May 2024

30 April 2024

28 April 2024

21 April 2024

19 April 2024

12 April 2024

8 April 2024

  • curprev 10:2910:29, 8 April 2024HansVonStuttgart talk contribsm 90,097 bytes −205 Undid revision 1217864590 by Radhika1309 (talk) see WP:TUTORIAL undo Tags: Undo Mobile edit Mobile web edit Advanced mobile edit
  • curprev 09:4409:44, 8 April 2024Radhika1309 talk contribs 90,302 bytes +205 There are several approaches to cancer immunotherapy: 1. Checkpoint Inhibitors: These drugs block inhibitory pathways in the immune system, such as PD-1 or CTLA-4, allowing immune cells to recognize and attack cancer cells more effectively. 2. CAR-T Cell Therapy: Chimeric Antigen Receptor (CAR) T-cell therapy involves genetically modifying a patient's T cells to express a receptor that recognizes specific proteins on cancer cells, leading to targeted destruction of those cells. 3. Monoclonal undo Tags: Reverted Visual edit Mobile edit Mobile web edit

5 April 2024

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)